News sentiment analysis powered by sentiment-insight.com
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should. While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. Zoetis managed to grow EPS by 12% per year, over three years. That growth rate is fairly good, assuming the company can keep it up.
'Shark Tank' investor Kevin O'Leary likely made over 20 times his money on a startup selling genetic-testing kits for cats Kevin O'Leary purchased a small stake in Basepaws, a startup offering at-home genetic testing for cats.Basepaws was acquired for over $50 million by Zoetis last year. If he paid $125,000 for a 5% stake, he would have made about $2.4 million.
Efforts To Protect Condors From Avian Influenza Move A Step Closer After successful trial involving black vultures, researchers now have begun vaccinating the endangered raptors. The vaccine being used is manufactured by Zoetis and targets highly pathogenic avian influenza.
France picks Germany's Boehringer Ingelheim for... France picks Germany's Boehringer Ingelheim for bird flu vaccines. Vaccination campaign to start in October. French firm Ceva Animal Health and U.S. company Zoetis had also applied.
Zoetis receives $15.3 million grant to improve livestock health in Sub-Saharan Africa The Bill & Melinda Gates Foundation has given Zoetis, an animal health company, a $15.3 million grant to “further develop and integrate innovative solutions to...
Topical therapy and immunotherapy can save time and frustration with dermatology cases Zoetis unveils Alphatrak 3 glucose monitoring system for cats and dogs.Improves in-clinic and at-home diabetes monitoring for more informed decisions.
Gilead (GILD) to Report Q4 Earnings: What's in the Cards? HomeStreet, Inc. is reporting for the quarter ending December 31, 2022. C.H. Robinson Worldwide CHRW is scheduled to report fourth-quarter 2022 results on Feb 1. United Therapeutics (UTHR) and Zoetis (ZTS) are two Medical - Drugs stocks.
4 Solid Stocks to Buy on Soaring Restaurant Sales Each of the three major U.S. stock indexes plummeted into a bear market last year. Shares of Medical Properties Trust Inc (Symbol: MPW) were yielding above the 9% mark. Zoetis (NYSE: ZTS) was losing ground in 2022 as the pet pharmacist saw headwinds.
Utah Republican has investments in companies he is regulating Rep. John Curtis (R-UT) revealed in his financial disclosure report for December 2022 that he's been trading stocks for some of the companies he's supposed to be regulating. With investments in UnitedHealth Group Incorporated Common Stock and the pharmaceutical company Zoetis, Curtis was offering legislation like the Increasing Access to Dental Insurance Act.
Sign Up
